Home » Topics » Regulatory

Regulatory
RSS

Olaparib receives E.U. approval for BRCA-mutated ovarian cancer

Dec. 19, 2014

FDA approves ear drop formulation of finafloxacin for acute otitis externa

Dec. 18, 2014

FDA approves nine-valent HPV vaccine Gardasil 9

Dec. 11, 2014

FDA approves Xgeva for hypercalcemia of malignancy

Dec. 9, 2014

Signifor approved in E.U. to treat acromegaly

Nov. 24, 2014

European Commission approves Duaklir Genuair for COPD

Nov. 24, 2014

FDA grants accelerated approval to Trumenba for prevention of meningococcal meningitis B

Oct. 30, 2014

FDA approves Baxter's Obizur for acquired hemophilia A

Oct. 27, 2014

FDA approves two idiopathic pulmonary fibrosis drugs ahead of schedule

Oct. 16, 2014

FDA approves netupitant/palonosetron combination for CINV

Oct. 13, 2014

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...